Senator Ron Wyden Calls $56Ka-Year Price of New Alzheimer's Drug 'Unconscionable'

Latest News & Information for the U.S. Senate

Sen. Chairman Ron Wyden (D-OR) questions Internal Revenue Service (IRS) Commissioner Charles Rettig during a Senate Finance Committee …

Full story here.

Originally published 2021-06-10 12:52:30 — www.newsweek.com

Leave a Reply